Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
10.52
+0.41 (4.06%)
Aug 5, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5144.6447.5421.251.54-
Revenue Growth
64.98%-6.09%123.69%1284.50%--
Gross Profit
47.0440.8844.3519.991.62-
Operating Income
-6.06-6.282.57-12.77-22.59-17.22
Net Income
-8.73-9.74-0.44-16.05-23.71-17.35
Earnings Per Share
-0.29-0.34-0.02-0.60-0.90-0.67
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
40.1836.7926.6313.2723.7721.1
Total Debt
0019.3430.9524.94.99
Net Cash (Debt)
40.1836.797.29-17.68-1.1316.11
Net Cash Growth
1108.76%404.36%----46.90%
Net Cash Per Share
1.851.290.27-0.67-0.040.62

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.78-12.4726.98-17.14-18.06-14.22
Free Cash Flow
-5.78-12.4726.98-17.14-18.06-14.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
92.23%91.57%93.30%94.08%105.60%-
Operating Margin
-11.87%-14.07%5.40%-60.09%-1471.60%-
Pretax Margin
-17.12%-21.58%-0.15%-75.50%-1544.89%-
Profit Margin
-17.12%-21.82%-0.92%-75.50%-1544.89%-
FCF Margin
-11.33%-27.94%56.75%-80.67%-1176.42%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
26.7515.8837.3690.856.326.32
P/FCF Ratio
--6.45---
PS Ratio
7.175.893.6613.92164.33-